Skip directly to page options Skip directly to A-Z link
Volume 16, Number 10—October 2010
Dispatch

Mortality Rate Patterns for Hemorrhagic Fever with Renal Syndrome Caused by Puumala Virus

Marika Hjertqvist, Sabra L. Klein, Clas Ahlm, and Jonas KlingströmComments to Author 
Author affiliations: Author affiliations: Swedish Institute for Infectious Disease Control, Solna, Sweden (M. Hjertqvist, J. Klingström); The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA (S.L. Klein); Umeå University, Umeå, Sweden (C. Ahlm, J. Klingström); Karolinska Institutet, Stockholm, Sweden (J. Klingström)

Main Article

Figure 1

Incidence of acute nephropathia epidemica (NE) and case-fatality rates, Sweden, 1997–2007. A) Age distribution for male and female patients with acute NE. B) Age distribution of case-fatality rates for all patients with acute NE. The Swedish Death Register was used to identify all deceased persons with a diagnosis of NE. Numbers of deaths during different periods after diagnoses were 21 (13 male patients and 8 female patients) during the acute phase (<3 months after diagnoses), 7 (5 male pati

Figure 1. Incidence of acute nephropathia epidemica (NE) and case-fatality rates, Sweden, 1997–2007. A) Age distribution for male and female patients with acute NE. B) Age distribution of case-fatality rates for all patients with acute NE. The Swedish Death Register was used to identify all deceased persons with a diagnosis of NE. Numbers of deaths during different periods after diagnoses were 21 (13 male patients and 8 female patients) during the acute phase (<3 months after diagnoses), 7 (5 male patients and 2 female patients) after the acute phase (>3 months after diagnoses) but <1 year later, and 24 (19 male patients and 5 female patients) during the second year after diagnoses.

Download

Main Article

Page created: September 07, 2011
Page updated: September 07, 2011
Page reviewed: September 07, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external